DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Asselah T, Lee SS, Yao BB. et al.
Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus genotype 5 or 6 infection (ENDURANCE-5,6): an open-label, multicentre, phase 3b trial.
Lancet Gastroenterol 2019;
4: 45-51
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.